Open, Classified

Model B35200 - Percept PC BrainSense Implantable Neurostimulator

FDA Recall Z-0418-2022 · Posted None

Recall StatusOpen, Classified

Product CodeMHY

Date Initiated2021-10-19

Product Quantity10,006 units

Reason for Recall

During cardioversion events, the Model B35200 Percept PC Implantable Neurostimulator could become unresponsive and non-functional. Cardioversion is a procedure performed by a cardiologist to correct an abnormal heartbeat. Medtronic has determined that the cardioversion may damage the circuit electronics in the Percept PC stimulator, thereby, causing the Percept PC stimulator to become non-responsive.

Firm Action

Medtronic distributed a correction notice via mail courier service to impacted U.S. consignees, delivered 06-October-2021. A second attempt to notify US consignees is scheduled for the week of 08-November-2021. A third attempt to notify US consignees is scheduled for the week of 10-Jan-2022. In addition to Medtronic s communications to Percept PC implanting and managing physicians, Medtronic will notify affected patients implanted with Percept PC INS devices of this issue in the US. US Patient notifications are scheduled to happen within a month s timeframe. Medtronic will retain delivery confirmations for all patient notification mailings.

Root Cause

Under Investigation by firm

Distribution Pattern

Worldwide distribution - US Nationwide and Puerto Rico. The countries of Australia, Canada, Austria, Belgium, Canary Islands, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Luxembourg, Netherlands, Norway, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, Switzerland, United Kingdom, India, Japan, Korea, Republic Of, Argentina, Brazil, Colombia, Thailand, and Hong Kong.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.